Topic specific news, updated constantly
from the most reliable sources, all in one place.
Other NewsOnly
Information Pages
Information Pages
Human Genome Sciences reports net income of $5.7 million for 2009 - Washington Post
Human Genome Sciences reports net income of $5.7 million for 2009 Washington Post The firm's drug, Benlysta, and Zalbin have both passed "Phase 3" testing. Stephen Dunn, an analyst with LifeTech Capital, said the HGS drug is ... Human Genome Sciences says CFO resigns Human Genome Sciences rises after 4Q report Human Genome Sciences Announces Fourth-Quarter and Full-Year 2009 Financial ... |
Human Genome Sciences Utilizes Aegis' Discoverant for Manufacturing Data ... - MarketWatch (press release)
Human Genome Sciences Utilizes Aegis' Discoverant for Manufacturing Data ... MarketWatch (press release) The HGS clinical development pipeline includes novel drugs to treat , hepatitis C, inhalation anthrax and cancer. HGS, Human Genome Sciences and ... Aegis Analytical Wins Human Genome Sciences |
Pond Skim, Canis , and Big …erts at The Canyons Next Weekend! - Freeskier Magazine
Pond Skim, Canis Lupus, and Big …erts at The Canyons Next Weekend! Freeskier Magazine The Pond Skim is just a warm-up for the next day's Canis Challenge – one of the best banked slaloms around. The course is a mile long natural halfpipe ... |
O'Brien's Lady may be in luck as Curragh welcomes Big star - Irish Independent
O'Brien's Lady may be in luck as Curragh welcomes Big star Irish Independent In the Group Three Lodge Park Stud EBF Park Express Stakes, the Wexford native sends out two three-year-olds, Devoted To You and Lady . ... |
Human Genome Sciences names David Southwell CFO - The Associated Press
Human Genome Sciences names David Southwell CFO The Associated Press It is aimed at suppressing the immune system's response to , an inflammatory disease prompting the body to attack its own tissue and organs. ... Human Genome Director Southwell to Be Finance Chief Human Genome Sciences: Novel Product Line, Significant Debt Reduction Human Genome Sciences names David Southwell CFO |
LFAGW to Launch Fourth Annual Walk for on April 17 - PR Newswire (press release)
LFAGW to Launch Fourth Annual Walk for Lupus on April 17 PR Newswire (press release) and his daughter, Mary Moran, will help cut the ribbon at the 4th Annual Walk for Now! Washington on Sat., April 17. As an honorary Walk co-chair, ... |
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation ... - MarketWatch (press release)
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation ... MarketWatch (press release) The HGS clinical development pipeline includes novel drugs to treat hepatitis C, , inhalation anthrax and cancer. HGS and Human Genome Sciences are ... Human Genome Sciences Announces Results Of Randomized Phase 2 Trial Of ... |
Workshop on set today - Visayan Daily Star
Workshop on lupus set today Visayan Daily Star “Living well with ,” a workshop for patients and their caregivers is scheduled today at the SV More Theatre in Bacolod City. It aims to teach patients ... |
Roche, Biogen Suffer Setback With Experimental Drug - Wall Street Journal
 The Hindu | Roche, Biogen Suffer Setback With Experimental Drug Wall Street Journal It follows earlier program halts in the ocrelizumab treatment of and rheumatoid arthritis, two autoimmune diseases. "The decision to put the trial on ... Roche, Biogen suspend Ocrelizumab treatment Arthritis and Lupus Drugs Pulled Off by Pharma Companies Biogen, Roche halt trial of drug |
SLE Foundation Selected as Charity Partner for ING New York City ... - Earthtimes (press release)
 Earthtimes (press release) | SLE Lupus Foundation Selected as Lupus Charity Partner for ING New York City ... Earthtimes (press release) Team Life Without The SLE Foundation has been selected as an official charity partner for the ING New York City Marathon 2010, which will take ... |